Oberweis Asset Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
OAM
DM
B
AIM
NAMA
Oberweis Asset Management's CDNA Position: Q3 2025 in Review
Oberweis Asset Management sold out of CareDx (CDNA) in Q3 2025, closing a stake of 292,871 shares — an estimated $5.72M sold.
Oberweis Asset Management first reported a position in CDNA in Q3 2018 and held it in 16 quarters. The position peaked at $9.23M in Q2 2019. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.
- Oberweis Asset Management reported no remaining CareDx position as of Q3 2025 after selling out during the quarter.
- Oberweis Asset Management sold 292,871 CareDx shares in Q3 2025, an estimated $5.72M.
- Oberweis Asset Management first reported a position in CareDx in Q3 2018 and held it in 16 quarters.
- Oberweis Asset Management's CareDx position peaked at $9.23M in Q2 2019.
- 187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.
Based on Oberweis Asset Management's 13F filing for Q3 2025, filed 17 Nov 2025.